26 results on '"Miyano, Kanako"'
Search Results
2. G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression
3. Infusions of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produce antidepressant-like effects on learned helplessness rats through BDNF-TrkB signaling and AMPA receptor activation, and strengthen learning ability
4. Possible mechanism for improving the endogenous immune system through the blockade of peripheral μ-opioid receptors by treatment with naldemedine
5. Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study
6. The Inhibition of TREK-1 K + Channels via Multiple Compounds Contained in the Six Kamikihito Components, Potentially Stimulating Oxytocin Neuron Pathways.
7. Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
8. G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression
9. Distinct Profiles of Desensitization of µ-Opioid Receptors Caused by Remifentanil or Fentanyl: In Vitro Assay with Cells and Three-Dimensional Structural Analyses
10. Listening carefully to the complaint and proposal of cancer patients yields novel and valuable drugs
11. The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the µ opioid receptor
12. Endothelin A receptor agonist ET-1 suppresses μ-opioid receptor activities with different efficacies caused by morphine or fentanyl
13. G protein-biased LPAR1 agonism promotes prototypic antidepressant effects
14. Japanese herbal kampo medicine individually contributes to alleviating side effects of cancer patients
15. Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways
16. Therapeutic Potential of Orally Administered Rubiscolin-6.
17. Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula
18. Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine
19. Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats
20. The Japanese Herbal Medicine Hangeshashinto Induces Oral Keratinocyte Migration by Mediating the Expression of CXCL12 Through the Activation of Extracellular Signal-Regulated Kinase
21. The First Structure-Activity Relationship Study of Oxytocin as a Positive Allosteric Modulator for the Μ Opioid Receptor
22. Therapeutic effects of voluntary wheel running on cancer cachexia-induced cardiac dysfunction: Approach from the perspective of Cardio-oncology
23. Atrophic effects by leukemia inhibitory factor (LIF) in 85As2 gastric cancer cell-inoculated cachexia model: in vitro analysis with C2C12 skeletal muscle cell line
24. A novel endothelin A receptor antagonist eliminates the analgesic tolerance and recovers the attenuated analgesic effects for long-term use of opioids
25. Identification of a Putative β‐Arrestin Superagonist of the Growth Hormone Secretagogue Receptor (GHSR).
26. Structure-Activity Relationship Study of CYM51010, an agonist for the µ-δ Opioid Receptor Heterodimer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.